Moderna's been anything but a high-flying growth stock in this investor's portfolio. So is it high time he gave up on this one? The post Moderna’s meant to be a red-hot growth stock. What on earth’s ...

In our analysis, these 12 brokerage accounts stand out as the best choices for stock trading, due to their low fees, strong platforms and quality customer support. Many, or all, of the products ...

RSV cases peaked earlier this month, but experts ask people to remain vigilant in preventing its spread. RSV is a respiratory ...

Most children will contract RSV by the time they turn 2 years old. These preventative tips can help limit the spread.

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...

A number of cases of Influenza A and RSV have been reported across the state, including right here in Central Texas. Making ...

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market ...

Care for the flu is generally supportive — meaning rest, hydration, and over-the-counter medication, but as the Mayo Clinic ...

Moderna is down 80% from its 52-week high as revenues continue to fall and the new RSV vaccine has performed poorly. Read my ...

Pfizer CEO highlights savings, leadership changes, and acquisition-driven growth amid significant revenue loss challenges ...

In the winter months, it seems few are safe from some kind of illness — flu, COVID-19, norovirus, colds. While many of the ...